Camrelizumab/LenvatinibCerebral haemorrhage and immune-related pneumonia: 2 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2038卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72179-3

中图分类号：

学科分类号：

摘要：

引用

页码：70 / 70

共 50 条

[31] AntineoplasticsBone marrow suppression, hyperprogressive disease and immune-related pneumonia: case report
Reactions Weekly, 2021, 1848 (1) : 52 - 52
[32] Immune-related myocarditis in two patients receiving camrelizumab therapy and document analysis
Zhang, Chuan
Qin, Shu
Zuo, Zhong
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (06) : 1350 - 1356
[33] AntineoplasticsLack of efficacy, immune-related hyperthermia and immune-related pneumonitis: case report
Reactions Weekly, 2021, 1864 (1) : 43 - 43
[34] PembrolizumabComplete atrioventricular block secondary to immune-related myocarditis: 3 case reports
Reactions Weekly, 2021, 1850 (1) : 228 - 228
[35] Hypophysitis: A rare but noteworthy immune-related adverse event secondary to camrelizumab therapy
Han, Xiaoying
Meng, Min
Zhang, Tiehong
Wang, Jiao
Huang, Guanghui
Ni, Yang
Li, Wenhong
Dai, Jianjian
Yang, Xia
Ye, Xin
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (05) : 1440 - 1443
[36] Camrelizumab/rivoceranibProteinuria and myocarditis: 2 case reports
Reactions Weekly, 2023, 1960 (1) : 116 - 116
[37] Camrelizumab/lenvatinibHypertension and hypothyroidism: 2 case reports
Reactions Weekly, 2024, 2035 (1) : 126 - 126
[38] Camrelizumab/sintilimabPneumonia and myocarditis: 2 case reports
Reactions Weekly, 2022, 1918 (1) : 118 - 118
[39] Camrelizumab-induced immune-related toxic epidermal necrolysis in lung adenocarcinoma: a case report and literature review
Sun, Man
Zhou, Huan
Zang, Dan
Liu, Chen-Guang
Chen, Jun
FRONTIERS IN ONCOLOGY, 2025, 14
[40] CisplatinPulmonary haemorrhage and haemorrhage: 2 case reports
Reactions Weekly, 2020, 1798 (1) : 84 - 84

← 1 2 3 4 5 →